Cassia Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$222K Hold
630
0.11% 63
2025
Q4
$206K Buy
+630
New +$200K 0.11% 62
2023
Q2
Sell
-1,634
Closed -$395K 61
2023
Q1
$395K Sell
1,634
-11
-0.7% -$2.7K 0.32% 26
2022
Q4
$432K Buy
+1,645
New +$441K 0.36% 27

Other funds holding AMGN

Cassia Capital Partners's AMGN Position: Q1 2026 in Review

Cassia Capital Partners held its Amgen (AMGN) position steady in Q1 2026 at 630 shares worth $222K. The position accounts for 0.11% of the portfolio, ranked #63.

Cassia Capital Partners first reported a position in AMGN in Q4 2022 and has held it in 4 quarters since. The position peaked at $432K in Q4 2022. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cassia Capital Partners held 630 shares of Amgen worth $222K as of Q1 2026.
  • Cassia Capital Partners left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.11% of Cassia Capital Partners's portfolio in Q1 2026, its #63 holding.
  • Cassia Capital Partners first reported a position in Amgen in Q4 2022 and has held it in 4 quarters since.
  • Cassia Capital Partners's Amgen position peaked at $432K in Q4 2022.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cassia Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.